149 related articles for article (PubMed ID: 17166832)
1. Structure-based inhibitor design for an enzyme that binds different steroids: a potent inhibitor for human type 5 17beta-hydroxysteroid dehydrogenase.
Qiu W; Zhou M; Mazumdar M; Azzi A; Ghanmi D; Luu-The V; Labrie F; Lin SX
J Biol Chem; 2007 Mar; 282(11):8368-79. PubMed ID: 17166832
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of human 17β-hydroxysteroid dehydrogenase type 1 complexed with estrone and NADP
Li T; Stephen P; Zhu DW; Shi R; Lin SX
FEBS J; 2019 Jun; 286(11):2155-2166. PubMed ID: 30768851
[TBL] [Abstract][Full Text] [Related]
3. The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors.
Breton R; Housset D; Mazza C; Fontecilla-Camps JC
Structure; 1996 Aug; 4(8):905-15. PubMed ID: 8805577
[TBL] [Abstract][Full Text] [Related]
4. Cofactor hydrogen bonding onto the protein main chain is conserved in the short chain dehydrogenase/reductase family and contributes to nicotinamide orientation.
Shi R; Lin SX
J Biol Chem; 2004 Apr; 279(16):16778-85. PubMed ID: 14966133
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5.
Lin SX; Shi R; Qiu W; Azzi A; Zhu DW; Dabbagh HA; Zhou M
Mol Cell Endocrinol; 2006 Mar; 248(1-2):38-46. PubMed ID: 16480815
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of the multispecific 17beta-hydroxysteroid dehydrogenase type 5: critical androgen regulation in human peripheral tissues.
Qiu W; Zhou M; Labrie F; Lin SX
Mol Endocrinol; 2004 Jul; 18(7):1798-807. PubMed ID: 15087468
[TBL] [Abstract][Full Text] [Related]
7. Cinnamic acids as new inhibitors of 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3).
Brozic P; Golob B; Gomboc N; Rizner TL; Gobec S
Mol Cell Endocrinol; 2006 Mar; 248(1-2):233-5. PubMed ID: 16337332
[TBL] [Abstract][Full Text] [Related]
8. A concerted, rational design of type 1 17beta-hydroxysteroid dehydrogenase inhibitors: estradiol-adenosine hybrids with high affinity.
Qiu W; Campbell RL; Gangloff A; Dupuis P; Boivin RP; Tremblay MR; Poirier D; Lin SX
FASEB J; 2002 Nov; 16(13):1829-31. PubMed ID: 12223444
[TBL] [Abstract][Full Text] [Related]
9. Structures of complexes of type 5 17β-hydroxysteroid dehydrogenase with structurally diverse inhibitors: insights into the conformational changes upon inhibitor binding.
Amano Y; Yamaguchi T; Niimi T; Sakashita H
Acta Crystallogr D Biol Crystallogr; 2015 Apr; 71(Pt 4):918-27. PubMed ID: 25849402
[TBL] [Abstract][Full Text] [Related]
10. Binary and ternary crystal structure analyses of a novel inhibitor with 17beta-HSD type 1: a lead compound for breast cancer therapy.
Mazumdar M; Fournier D; Zhu DW; Cadot C; Poirier D; Lin SX
Biochem J; 2009 Dec; 424(3):357-66. PubMed ID: 19929851
[TBL] [Abstract][Full Text] [Related]
11. Steroid recognition and regulation of hormone action: crystal structure of testosterone and NADP+ bound to 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase.
Bennett MJ; Albert RH; Jez JM; Ma H; Penning TM; Lewis M
Structure; 1997 Jun; 5(6):799-812. PubMed ID: 9261071
[TBL] [Abstract][Full Text] [Related]
12. Mouse 17alpha-hydroxysteroid dehydrogenase (AKR1C21) binds steroids differently from other aldo-keto reductases: identification and characterization of amino acid residues critical for substrate binding.
Faucher F; Cantin L; Pereira de Jésus-Tran K; Lemieux M; Luu-The V; Labrie F; Breton R
J Mol Biol; 2007 Jun; 369(2):525-40. PubMed ID: 17442338
[TBL] [Abstract][Full Text] [Related]
13. Unusual charge stabilization of NADP+ in 17beta-hydroxysteroid dehydrogenase.
Mazza C; Breton R; Housset D; Fontecilla-Camps JC
J Biol Chem; 1998 Apr; 273(14):8145-52. PubMed ID: 9525918
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of human type III 3alpha-hydroxysteroid dehydrogenase/bile acid binding protein complexed with NADP(+) and ursodeoxycholate.
Jin Y; Stayrook SE; Albert RH; Palackal NT; Penning TM; Lewis M
Biochemistry; 2001 Aug; 40(34):10161-8. PubMed ID: 11513593
[TBL] [Abstract][Full Text] [Related]
15. Amino acid substitution of arginine 80 in 17beta-hydroxysteroid dehydrogenase type 3 and its effect on NADPH cofactor binding and oxidation/reduction kinetics.
McKeever BM; Hawkins BK; Geissler WM; Wu L; Sheridan RP; Mosley RT; Andersson S
Biochim Biophys Acta; 2002 Nov; 1601(1):29-37. PubMed ID: 12429500
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of type 2 17beta-hydroxysteroid dehydrogenase by estradiol derivatives bearing a lactone on the D-ring: structure-activity relationships.
Bydal P; Auger S; Poirier D
Steroids; 2004 May; 69(5):325-42. PubMed ID: 15219411
[TBL] [Abstract][Full Text] [Related]
17. Structure of the ternary complex of human 17beta-hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+.
Sawicki MW; Erman M; Puranen T; Vihko P; Ghosh D
Proc Natl Acad Sci U S A; 1999 Feb; 96(3):840-5. PubMed ID: 9927655
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of human prostaglandin F synthase (AKR1C3).
Komoto J; Yamada T; Watanabe K; Takusagawa F
Biochemistry; 2004 Mar; 43(8):2188-98. PubMed ID: 14979715
[TBL] [Abstract][Full Text] [Related]
19. Crystal structures of mouse 17alpha-hydroxysteroid dehydrogenase (apoenzyme and enzyme-NADP(H) binary complex): identification of molecular determinants responsible for the unique 17alpha-reductive activity of this enzyme.
Faucher F; Pereira de Jésus-Tran K; Cantin L; Luu-The V; Labrie F; Breton R
J Mol Biol; 2006 Dec; 364(4):747-63. PubMed ID: 17034817
[TBL] [Abstract][Full Text] [Related]
20. Human dehydrogenase/reductase SDR family member 11 (DHRS11) and aldo-keto reductase 1C isoforms in comparison: Substrate and reaction specificity in the reduction of 11-keto-C
Endo S; Morikawa Y; Kudo Y; Suenami K; Matsunaga T; Ikari A; Hara A
J Steroid Biochem Mol Biol; 2020 May; 199():105586. PubMed ID: 31926269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
